HIGHLIGHTS
- who: Yan Gao from the Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No32, Renmin Road, Shiyan, China have published the research work: eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma, in the Journal: (JOURNAL)
- what: This study evaluated the correlation between eIF6 expression and metabolic analysis using fluorine-18 fluorodeoxyglucose -Positron emission tomography (PET) and gene in ESCA. The Bulk RNA gene analysis revealed a significant inverse association † and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.